H.R. 3214 (112th): Food and Drug Administration Mission Reform Act of 2011

Oct 14, 2011 (112th Congress, 2011–2013)
Died (Referred to Committee)
See Instead:

S. 1972 (same title)
Referred to Committee — Dec 08, 2011

Mike Rogers
Representative for Michigan's 8th congressional district
Read Text »
Last Updated
Oct 14, 2011
3 pages
Related Bills
S. 1972 (Related)
Food and Drug Administration Mission Reform Act of 2011

Referred to Committee
Last Action: Dec 08, 2011


This bill was introduced on October 14, 2011, in a previous session of Congress, but was not enacted.

Introduced Oct 14, 2011
Referred to Committee Oct 14, 2011
Full Title

To amend the Food and Drug Administration's mission.


No summaries available.

10 cosponsors (10R) (show)

House Energy and Commerce


The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Food and Drug Administration Mission Reform Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise the mission of the Food and Drug Administration (FDA) to include establishment of a regulatory system that:
(1) advances medical innovation by incorporating modern scientific tools, standards, and approaches;
(2) protects the public health and enables patients to access novel products while promoting economic growth, innovation, competitiveness, and job creation among the industries regulated by the FFDCA;
(3) is based on the best available science;
(4) allows for public participation and an open exchange of ideas;
(5) promotes predictability, allows flexibility, and reduces uncertainty;
(6) identifies and uses the most innovative and least burdensome tools for achieving regulatory ends;
(7) ensures that regulations are accessible, consistent, transparent, written in plain language, and easy to understand;
(8) measures, and seeks to improve, the actual results of regulatory requirements; and
(9) incorporates a patient-focused benefit-risk framework that accounts for varying degrees of risk tolerance.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 3214 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus